Hemodialysis Patient
Conditions
Brief summary
To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.
Interventions
OTHERneutrophil lymphocyte ratio and platelet lymphocyte ratio
explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients
Sponsors
Sohag University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Months to No maximum
Healthy volunteers
No
Inclusion criteria
* All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR
Exclusion criteria
* • Patients aged \< 18 years old. * Patient with autoimmune disease. * Patient with liver cirrhosis. * Patients with immunodeficiency. * Patients with malignancy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 6 months | The primary outcome measures in the study High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis is :- All-cause mortality, encompassing death from any cause These is the endpoint used to evaluate the prognostic significance of NLR and PLR in hemodialysis patients. |
Countries
Egypt
Outcome results
None listed